Company Data
iTeos Therapeutics Inc.
Ticker
ITOS
Current Price
$10 -0.3%
Market Cap
$382.7M
Price Target
Refer to Report
Volume
1.3M
52wk Range
$4.8 - $18.13
Overview
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.